Managing dementia and Parkinson’s disease - PowerPoint PPT Presentation

1 / 61
About This Presentation
Title:

Managing dementia and Parkinson’s disease

Description:

Managing dementia and Parkinson s disease Graham Lennox Addenbrooke s Hospital, Cambridge Regent s College, September 2006 Plan The concept of Lewy body disease ... – PowerPoint PPT presentation

Number of Views:267
Avg rating:3.0/5.0
Slides: 62
Provided by: bjhmCoU7
Category:

less

Transcript and Presenter's Notes

Title: Managing dementia and Parkinson’s disease


1
Managing dementia and Parkinsons disease
  • Graham Lennox
  • Addenbrookes Hospital, Cambridge
  • Regents College, September 2006

2
Plan
  • The concept of Lewy body disease
  • Prodromes to dementia
  • Dementia in Parkinsons disease

3
Pathology
4
The concept of Lewy body disease
5
In the brainstem Parkinsons disease
6
In the brainstem Parkinsons diseaseIn the
cortex dementia
7
Prodromes to dementia
8
Prodromes to dementia
  • Parkinsons disease

9
Prodromes to dementia
  • Parkinsons disease
  • Subtle cognitive impairment is the norm

10
Prodromes to dementia
  • Parkinsons disease
  • Subtle cognitive impairment is the norm
  • Cross-sectional prevalence of dementia is about
    30

11
Prodromes to dementia
  • Parkinsons disease
  • Subtle cognitive impairment is the norm
  • Cross-sectional prevalence of dementia is about
    30
  • Cumulative incidence of dementia is about 80

12
Prodromes to dementia
  • Parkinsons disease
  • Subtle cognitive impairment is the norm
  • Cross-sectional prevalence of dementia is about
    30
  • Cumulative incidence of dementia is about 80
  • Age is the main risk factor

13
Prodromes to dementia
  • Parkinsons disease
  • Sleep disturbance

14
Prodromes to dementia
  • Parkinsons disease
  • Sleep disturbance
  • REM sleep behaviour disorder
  • Daytime somnolence

15
REM sleep behaviour disorder
  • Acting out dreams

16
REM sleep behaviour disorder
  • Acting out dreams
  • Common, potentially hazardous

17
REM sleep behaviour disorder
  • Acting out dreams
  • Common, potentially hazardous
  • Clonazepam
  • Long half-life, titrate up from 0.125mg

18
Daytime somnolence
  • Poor night-time sleep

19
Daytime somnolence
  • Poor night-time sleep
  • RSBD
  • Sleep apnoea
  • Restless legs/periodic limb movements
  • Depression
  • Discomfort from immobility
  • Incidental causes eg nocturia

20
Daytime somnolence
  • Poor night-time sleep
  • RSBD
  • Sleep apnoea
  • Restless legs/periodic limb movements
  • Depression
  • Discomfort from immobility
  • Incidental causes eg nocturia
  • Medication

21
Daytime somnolence
  • Siesta
  • Treat the cause if possible
  • Perhaps amantadine or selegiline
  • Possibly modafinil

22
Prodromes to dementia
  • Parkinsons disease
  • Sleep disturbance
  • Depression

23
Depression
  • Common, part of the disease
  • Look for it
  • Ask about low mood, anhedonia and apathy

24
Depression
  • Common, part of the disease
  • Look for it
  • Ask about low mood, anhedonia and apathy
  • Easy to treat
  • Trials in progress
  • Citalopram, venlafaxine, chlomipramine

25
Dementia
  • The dark secret of Parkinsons disease

26
The pattern of dementia
  • Memory
  • Language
  • Visuospatial skills

27
but
  • More frontal than Alzheimers patients

28
but
  • More frontal than Alzheimers patients
  • And more visuospatial impairment

29
(No Transcript)
30
Additional features
  • Visual hallucinations
  • Cognitive fluctuations

31
Visual hallucinations
32
Visual hallucinations
  • Detailed but sometimes distorted

33
Visual hallucinations
  • Detailed but sometimes distorted
  • People and animals
  • (or grids and patterns)

34
Visual hallucinations
  • Detailed but sometimes distorted
  • People and animals
  • (or grids and patterns)
  • Often some insight misperceptions

35
Visual hallucinations
  • Sometimes accompanying auditory or sensory
    hallucinations
  • Often accompanying delusions

36
Cognitive fluctuations
  • Variable attention

37
Cognitive fluctuations
  • Variable attention
  • Episodes of confusion
  • Good and bad days
  • Fluctuation over hours
  • Daytime drowsiness
  • Staring into space

38
Epidemiology
  • Dementia in PD
  • Cross-sectional prevalence 20-40
  • Cumulative incidence 80
  • Prevalence in over 65 population 0.3
  • Dementia with Lewy bodies
  • Dementia autopsies 15-20
  • Finnish over 75s with dementia 22
  • Prevalence in entire over 65 population 0.7

39
  • More than 20 of the workload of old age
    psychiatry services

40
Differential diagnosis
  • PD plus coincidental dementia
  • Small vessel ischaemia
  • Alzheimers disease
  • Rare secondary dementia

41
Investigations
  • Dementia screen blood tests
  • Very low yield in typical cases

42
Investigations
  • Dementia screen blood tests
  • Very low yield in typical cases
  • CT brain scan
  • Picks up vascular disease in cases with risk
    factors for this
  • Rules out hydrocephalus and frontal meningioma in
    very frontal cases

43
Treatment
44
Treatment
  • Explanation

45
Treatment
  • Explanation
  • Timing this is sensitive and difficult

46
Treatment
  • Explanation
  • Timing this is sensitive and difficult
  • Dementia is the last taboo

47
Treatment
  • Explanation
  • Timing this is sensitive and difficult
  • Dementia is the last taboo
  • It helps that the discussion is usually in the
    context of treatment

48
Treatment
  • Cholinesterase inhibitors
  • Good for hallucinations
  • Quite good for cognitive fluctuations
  • Sometimes help baseline cognition

49
Treatment
  • Cholinesterase inhibitors
  • Good for hallucinations
  • Quite good for cognitive fluctuations
  • Sometimes help baseline cognition
  • NNT about 2
  • Agitation and diarrhoea
  • Rivastigmine/galantamine gt donepezil

50
Other treatment options
  • Withdraw non-essential aggravating PD drugs
  • anticholinergics
  • selegiline
  • amantadine
  • dopamine agonists
  • Usually leave levodopa

51
Other treatment options
  • Withdraw aggravating PD drugs
  • Improve eyesight/lighting

52
Other treatment options
  • Withdraw aggravating PD drugs
  • Improve eyesight/lighting
  • Very atypical neuroleptics
  • Clozapine
  • Possibly (high-dose) quetiapine
  • Possibly aripiprazole etc

53
Other treatment options
  • Withdraw aggravating PD drugs
  • Improve eyesight/lighting
  • Very atypical neuroleptics
  • Consider depression

54
Other treatment options
  • Withdraw aggravating PD drugs
  • Improve eyesight/lighting
  • Very atypical neuroleptics
  • Consider depression
  • Practical support

55
Prognosis
  • The combination of physical and mental disability
    is bad for
  • Carer burden
  • Care cost
  • Survival

56
Prevention
  • Education and mental activity

57
Prevention
  • Education and mental activity
  • Neuroprotection?

58
Prevention
  • Education and mental activity
  • Neuroprotection?
  • Dementia should be an endpoint in neuroprotection
    studies

59
Summary
  • Dementia with Lewy bodies and Parkinsons disease
    with dementia are different faces of the same
    disease

60
Summary
  • Dementia with Lewy bodies and Parkinsons disease
    with dementia are different faces of the same
    disease
  • Dementia is very common in older people with
    Parkinsons disease

61
Summary
  • Think of Parkinsons disease as a dementia with a
    motor prodrome
  • Think of better approaches to prevention and
    treatment existing therapies help, but managing
    dementia remains our biggest challenge in
    Parkinsons disease
Write a Comment
User Comments (0)
About PowerShow.com